DS-8201a
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Adenocarcinoma, Gastric
Conditions
Adenocarcinoma, Gastric, Neoplasm, Breast
Trial Timeline
Apr 2, 2018 → Sep 28, 2022
NCT ID
NCT03368196About DS-8201a
DS-8201a is a phase 1 stage product being developed by Daiichi Sankyo for Adenocarcinoma, Gastric. The current trial status is completed. This product is registered under clinical trial identifier NCT03368196. Target conditions include Adenocarcinoma, Gastric, Neoplasm, Breast.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (5)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04132960 | Phase 2 | Completed |
| NCT03368196 | Phase 1 | Completed |
| NCT03384940 | Phase 2 | Completed |
| NCT03366428 | Phase 1 | Completed |
| NCT03248492 | Phase 2 | Terminated |
Competing Products
20 competing products in Adenocarcinoma, Gastric